Pathogenic protozoa of the genus Leishmania pose a significant burden on global health. Control relies on a limited range of chemotherapeutic options, with amphotericin B of increasing importance. Understanding how resistance may emerge to this drug is therefore of some concern. As amphotericin B acts through its affinity for leishmanial sterols, altered sterol composition has been described. However, little is known about the genetic basis of these changes. In this thesis, selection and characterisation of four novel amphotericin B-resistant L. mexicana lines are described. Changes to parasite drug sensitivity and fitness were profiled, as well as alterations in metabolism. This revealed heterogeneity between lines, suggesting that many...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
The Wellcome Trust (https://wellcome.ac.uk/) funded MB through awards 104111/Z/14/Z and 105614/Z/14/...
The Wellcome Trust (https://wellcome.ac.uk/) funded MB through awards 104111/Z/14/Z and 105614/Z/14/...
Pathogenic protozoa of the genus Leishmania pose a significant burden on global health. Control reli...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
<div><p>Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Admin...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B is an increasingly important tool in efforts to reduce the global disease burden pose...
Amphotericin B is an increasingly important tool in efforts to reduce the global disease burden pose...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
The Wellcome Trust (https://wellcome.ac.uk/) funded MB through awards 104111/Z/14/Z and 105614/Z/14/...
The Wellcome Trust (https://wellcome.ac.uk/) funded MB through awards 104111/Z/14/Z and 105614/Z/14/...
Pathogenic protozoa of the genus Leishmania pose a significant burden on global health. Control reli...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
<div><p>Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Admin...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B is an increasingly important tool in efforts to reduce the global disease burden pose...
Amphotericin B is an increasingly important tool in efforts to reduce the global disease burden pose...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
Amphotericin B has emerged as the therapy of choice for use against the leishmaniases. Administratio...
The Wellcome Trust (https://wellcome.ac.uk/) funded MB through awards 104111/Z/14/Z and 105614/Z/14/...
The Wellcome Trust (https://wellcome.ac.uk/) funded MB through awards 104111/Z/14/Z and 105614/Z/14/...